Moleculin Biotech, Inc. <MBRX.O>: H.C. Wainwright cuts target price to $3 from $22
MBRX•Related News
iBio FY26 net loss widens to $33.04 million; revenue drops to $100,000
IBIO•
Dollar General <DG.N>: Deutsche Bank Raises Target Price to $130 From $126
DG•
PayPal shares tumble on report Advent-Stripe consortium drops buyout bid
PYPL•
Iran war mediators focus on reopening Strait of Hormuz
XLE•
Dollar General general counsel Rhonda Taylor to retire; Kelly Collier to succeed in 2026
DG•